共 213 条
- [1] Grantham JJ(2008)Clinical practice. Autosomal dominant polycystic kidney disease N Engl J Med 359 1477-1485
- [2] Harris PC(2009)Polycystic kidney disease Annu Rev Med 60 321-337
- [3] Torres VE(2013)New treatments for autosomal dominant polycystic kidney disease Brit J Clin Pharm 76 524-535
- [4] Chang M-Y(1988)A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 411-415
- [5] Ong ACM(1993)Endothelins: Multifunctional renal peptides Physiol Rev 73 375-411
- [6] Yanagisawa M(2008)Endothelin: 20 years from discovery to therapy Can J Physiol Pharmacol 86 485-498
- [7] Kurihara H(1997)Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension J Clin Invest 99 1380-1389
- [8] Kimura S(1992)Attenuated expression of epithelial cell adhesion molecules in murine polycystic kidney disease Am J Physiol Renal Physiol 262 F679-F686
- [9] Tombe Y(1993)Increased endothelin and endothelin receptor mRNA expression in polycystic kidneys of cpk mice J Am Soc Nephrol 4 1064-1072
- [10] Kobayashi M(1998)Renal endothelin system in polycystic kidney disease J Am Soc Nephrol 9 1169-1177